Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticals.

about

Next generation ligand binding assays-review of emerging technologies' capabilities to enhance throughput and multiplexing.Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis: a comprehensive overview of methodology pitfalls and benefits.

P2860

Q35318295-B0AEBE17-1A77-492A-A419-2C170E574C25 Q38898145-F836AC2E-2D56-4162-A33B-A3A8B039C0A4

P2860

Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticals.

Item

http://www.wikidata.org/entity/Q38046653

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Improved analytical methods fo ...... ibodies to biopharmaceuticals.

@en

type

Item

label

Improved analytical methods fo ...... ibodies to biopharmaceuticals.

@en

prefLabel

Improved analytical methods fo ...... ibodies to biopharmaceuticals.

@en

P1476

Improved analytical methods fo ...... ibodies to biopharmaceuticals.

@en

P2093

Christophe Lallemand

http://www.w3.org/2001/XMLSchema#string

Michael G Tovey

http://www.w3.org/2001/XMLSchema#string

P2860

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.

Thrombocytopenia caused by the development of antibodies to thrombopoietin.

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

Treatment of chronic myeloid leukemia with interferon alpha (Roferon): results of the Israeli Study Group on CML.

First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab.

Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.

The neutralization of interferons by antibody III. The constant antibody bioassay, a highly sensitive quantitative detector of low antibody levels

Quantification of the neutralization of cytokine biological activity by antibody: the ten-fold reduction bioassay of interleukin-6 as growth factor.

Biological assays for interferons.

Antibodies against interferon-beta in multiple sclerosis.

P304

2179-2190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/BIO.12.186

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23013400

http://www.w3.org/2001/XMLSchema#string

Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticals.

about

P2860

P2860

Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticals.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698